Europe Glioblastoma Market and Competitive Landscape - 2017 - Product Image

Europe Glioblastoma Market and Competitive Landscape - 2017

  • ID: 4377698
  • Report
  • Region: Europe
  • Fore Pharma
1 of 3
The latest research, Europe Glioblastoma Market and Competitive Landscape - 2017, provides comprehensive insights into Glioblastoma pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Glioblastoma market size and drug sales. This research also provides insights into Glioblastoma epidemiology and late stage pipeline.

The report is classified into nine sections - Glioblastoma overview with definitions, symptoms, etiology, diagnosis, treatment options; Glioblastoma pipeline insights covering late stage clinical trials pipeline; Glioblastoma prevalence trends by countries; Glioblastoma market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries - Germany, France, Italy, Spain, UK, Europe.

Research Scope:
  • Glioblastoma pipeline: Find out the drugs in clinical trials for Glioblastoma by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Glioblastoma epidemiology: Find out the prevalence of Glioblastoma by countries - Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Glioblastoma products: Identify key products marketed and prescribed for Glioblastoma by brand name, by molecule, by company, by branded / generic, by countries - Europe, Germany, France, Italy, Spain, UK, Japan
  • Glioblastoma market size: Find out the market size for Glioblastoma drugs by countries - Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Glioblastoma drug sales: Find out the sales of Glioblastoma drugs by countries - Europe, Germany, France, Italy, Spain, UK
  • Glioblastoma drugs sales forecast: Sales forecast for Glioblastoma drugs to 2021 by countries - Europe, Germany, France, Italy, Spain, UK, Japan
  • Glioblastoma market share analysis: Find out the market shares of Glioblastoma drugs and outlook by countries - Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Glioblastoma drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Glioblastoma market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Glioblastoma market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


This report will take 1-2 business days to deliver.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Glioblastoma: Disease Overview
1.1. Glioblastoma Symptoms
1.2. Glioblastoma Etiology
1.3. Glioblastoma Diagnosis
1.4. Glioblastoma Treatment Options

2. Glioblastoma Pipeline Insights
2.1. Glioblastoma Phase 3 Clinical Trials
2.2. Glioblastoma Phase 2 Clinical Trials
2.3. Glioblastoma Phase 1 Clinical Trials

3. Glioblastoma Epidemiology Analysis

4. Germany Glioblastoma Market Insights
4.1. Marketed Products for Glioblastoma in Germany
4.2. Germany Glioblastoma Market Size & Forecast
4.3. Germany Glioblastoma Product Sales Forecast
4.4. Germany Glioblastoma Market Share Analysis

5. France Glioblastoma Market Insights
5.1. Marketed Products for Glioblastoma in France
5.2. France Glioblastoma Market Size & Forecast
5.3. France Glioblastoma Product Sales Forecast
5.4. France Glioblastoma Market Share Analysis

6. Italy Glioblastoma Market Insights
6.1. Marketed Products for Glioblastoma in Italy
6.2. Italy Glioblastoma Market Size & Forecast
6.3. Italy Glioblastoma Product Sales Forecast
6.4. Italy Glioblastoma Market Share Analysis

7. Spain Glioblastoma Market Insights
7.1. Marketed Products for Glioblastoma in Spain
7.2. Spain Glioblastoma Market Size & Forecast
7.3. Spain Glioblastoma Product Sales Forecast
7.4. Spain Glioblastoma Market Share Analysis

8. UK Glioblastoma Market Insights
8.1. Marketed Products for Glioblastoma in UK
8.2. UK Glioblastoma Market Size & Forecast
8.3. UK Glioblastoma Product Sales Forecast
8.4. UK Glioblastoma Market Share Analysis

9. Europe Glioblastoma Market Insights
9.1. Europe Glioblastoma Market Size & Forecast
9.2. Europe Glioblastoma Product Sales Forecast
9.3. Europe Glioblastoma Market Share Analysis

10. Research Methodology

List of Tables:
Table 1: Glioblastoma Phase 3 Clinical Trials, Global, 2017
Table 2: Glioblastoma Phase 2 Clinical Trials, Global, 2017
Table 3: Glioblastoma Phase 1 Clinical Trials, Global, 2017
Table 4: Glioblastoma Prevalence by EU5 Countries, 2012 - 2021
Table 5: Marketed Products for Glioblastoma in Germany, 2017
Table 6: Germany Glioblastoma Market Size & Forecast ($mn), 2012 - 2021
Table 7: Germany Glioblastoma Product Sales ($mn), 2012 - 2021
Table 8: Germany Glioblastoma Market Trends, 2012 - 2021
Table 9: Marketed Products for Glioblastoma in France, 2017
Table 10: France Glioblastoma Market Size & Forecast ($mn), 2012 - 2021
Table 11: France Glioblastoma Product Sales ($mn), 2012 - 2021
Table 12: France Glioblastoma Market Trends, 2012 - 2021
Table 13: Marketed Products for Glioblastoma in Italy, 2017
Table 14: Italy Glioblastoma Market Size & Forecast ($mn), 2012 - 2021
Table 15: Italy Glioblastoma Product Sales ($mn), 2012 - 2021
Table 16: Italy Glioblastoma Market Trends, 2012 - 2021
Table 17: Marketed Products for Glioblastoma in Spain, 2017
Table 18: Spain Glioblastoma Market Size & Forecast ($mn), 2012 - 2021
Table 19: Spain Glioblastoma Product Sales ($mn), 2012 - 2021
Table 20: Spain Glioblastoma Market Trends, 2012 - 2021
Table 21: Marketed Products for Glioblastoma in UK, 2017
Table 22: UK Glioblastoma Market Size & Forecast ($mn), 2012 - 2021
Table 23: UK Glioblastoma Product Sales ($mn), 2012 - 2021
Table 24: UK Glioblastoma Market Trends, 2012 - 2021
Table 25: Europe Glioblastoma Market Size & Forecast ($mn), 2012 - 2021
Table 26: Europe Glioblastoma Product Sales ($mn), 2012 - 2021

List of Figures:
Figure 1: Glioblastoma Pipeline by Phase (%), Global, 2017
Figure 2: Glioblastoma Prevalence by EU5 Countries, 2012 - 2021
Figure 3: Germany Glioblastoma Market Size ($mn), 2012 - 2021
Figure 4: Germany Glioblastoma Product Sales ($mn), 2012 - 2021
Figure 5: Germany Glioblastoma Market Share by Products (%), 2016
Figure 6: Germany Glioblastoma Market - Future Market Share (%), 2021
Figure 7: France Glioblastoma Market Size ($mn), 2012 - 2021
Figure 8: France Glioblastoma Product Sales ($mn), 2012 - 2021
Figure 9: France Glioblastoma Market Share by Products (%), 2016
Figure 10: France Glioblastoma Market - Future Market Share (%), 2021
Figure 11: Italy Glioblastoma Market Size ($mn), 2012 - 2021
Figure 12: Italy Glioblastoma Product Sales ($mn), 2012 - 2021
Figure 13: Italy Glioblastoma Market Share by Products (%), 2016
Figure 14: Italy Glioblastoma Market - Future Market Share (%), 2021
Figure 15: Spain Glioblastoma Market Size ($mn), 2012 - 2021
Figure 16: Spain Glioblastoma Product Sales ($mn), 2012 - 2021
Figure 17: Spain Glioblastoma Market Share by Products (%), 2016
Figure 18: Spain Glioblastoma Market - Future Market Share (%), 2021
Figure 19: UK Glioblastoma Market Size ($mn), 2012 - 2021
Figure 20: UK Glioblastoma Product Sales ($mn), 2012 - 2021
Figure 21: UK Glioblastoma Market Share by Products (%), 2016
Figure 22: UK Glioblastoma Market - Future Market Share (%), 2021
Figure 23: Europe Glioblastoma Market Size ($mn), 2012 - 2021
Figure 24: Europe Glioblastoma Product Sales ($mn), 2012 - 2021
Figure 25: Europe Glioblastoma Market Share by Products (%), 2016
Figure 26: Europe Glioblastoma Market - Future Market Share (%), 2021
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll